(Q46859854)

25 December 2017

review article

1 reference

title

Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease (English)

1 reference

25 December 2017

inflammatory bowel diseases

main subject

0 references

inflammation

0 references

author name string

Friend DR

series ordinal

1

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

25 December 2017

Alimentary Pharmacology & Therapeutics

published in

1 reference

25 December 2017

volume

12

1 reference

25 December 2017

issue

7

1 reference

25 December 2017

page(s)

591-603

1 reference

25 December 2017

Targeting of drugs and vaccines to the gut.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Microbially controlled drug delivery to the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Biochemistry, molecular biology, and physiology of the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Glucocorticosteroid therapy: mechanisms of action and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Cell-mediated immunity in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Cortisone in ulcerative colitis; preliminary report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Clinical Pharmacokinetics of Prednisone and Prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Corticosteroids: clinical pharmacology and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Steroid complications in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Rectally administered prednisolone--evidence for a predominantly local action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Treatment of distal ulcerative colitis with beclomethasone enemas: high therapeutic efficacy without endocrine side effects. A prospective, randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Betamethasone enemata in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

A budesonide prodrug accelerates treatment of colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

The oral systemic availability of fluticasone propionate in man--preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Fluticasone propionate in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Oral fluticasone propionate in active distal ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Measurement of gastrointestinal pH profiles in normal ambulant human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Transit of pharmaceutical dosage forms through the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Symptoms and stool patterns in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Faecal stasis in proctocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

The rectal mucosa-associated microflora in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

The faecal flora of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Influence of inflammatory bowel disease on intestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

Fractal growth viscous fingers: quantitative characterization of a fluid instability phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00348.X

10.1046/J.1365-2036.1998.00348.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017